COMMUNIQUÉS West-GlobeNewswire

Globus Medical Showcases Latest Innovations at NASS 2019
19/09/2019
Technologies featured include Single Position Lateral Surgery driven by ExcelsiusGPS® Interbody Solutions AUDUBON, Pa., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal [...]
Prevail Therapeutics Announces Addition to Russell 2000®, 3000® and Microcap® Indexes
19/09/2019
NEW YORK, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL) (“Prevail” or “the Company”), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients [...]
Kiniksa Presents Preclinical Data Supporting KPL-716 Clinical Development at the 49th Annual Meeting of the European Society of Dermatological Research
19/09/2019
Data reinforce the scientific evidence supporting the potential treatment of chronic pruritic diseases through OSMRβ inhibition HAMILTON, Bermuda, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq [...]
HTG Molecular Diagnostics Announces Proposed Public Offering of Common Stock
19/09/2019
TUCSON, Ariz., Sept. 19, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that it intends to offer and [...]
Galapagos increases share capital through warrant exercises
19/09/2019
Mechelen, Belgium; 19 September 2019, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 301,745 new [...]
Transparency notification
19/09/2019
Mechelen, Belgium; 19 september 2019; 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Sands Capital Management, LLC . Pursuant to Belgian [...]
Monthly information regarding the total number of voting rights and total number of shares of the Company
19/09/2019
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
19/09/2019
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
Parallax Health Sciences Announces Acquisition of Minority Interest In Global Career Networks
19/09/2019
SANTA MONICA, CA, Sept. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, today announces it [...]
Blood Advances Publishes Cellworks Prospective Genomic Biosimulation Study that Predicts Cancer Therapy Response with 90% Accuracy
19/09/2019
Study Uses NGS Data with Biosimulation to Predict Drug Response in AML and MDS Patients SAN FRANCISCO, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a leader in Precision Medicine and a global pioneer of [...]
Genkyotex Announces First Half 2019 Results
19/09/2019
Final setanaxib phase 2 results in PBC showed statistical significance for primary endpoint when corrected for non-normal variability Data to be presented at an upcoming international scientific conference WHO [...]
Genkyotex publie ses résultats semestriels 2019
19/09/2019
Les résultats complets de l’essai clinique de phase 2 avec le setanaxib en CBP montrent une différence statistiquement significative du paramètre principal après correction des aberrations de distribution Présentation [...]
Valneva Confirms Delisting from the Vienna Stock Exchange
19/09/2019
Valneva Confirms Delisting from the Vienna Stock Exchange Last VSE trading day will take place on December 20, 2019 Valneva shares will be automatically transferred to Euronext Paris Valneva’s listing on Euronext Paris [...]
Valneva confirme le retrait de ses actions de la Bourse de Vienne
19/09/2019
Valneva confirme le retrait de ses actions de la Bourse de Vienne Dernier jour de cotation des actions à la bourse de Vienne (VSE) le 20 décembre 2019 Les actions Valneva seront automatiquement transférées sur Euronext [...]
PSIQ Terminates Letter of Intent to Acquire Ecoland
19/09/2019
SUNRISE, Fla., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC: PSIQ) announces that effective August 21 st 2019, the letter of intent dated April 27 th 2019 to acquire 80% of Ecoland K.K.L. LTD and [...]
BrainsWay Announces Further Leadership Transition to U.S.
19/09/2019
Company Intends to Appoint U.S.-Based CEO JERUSALEM and HACKENSACK, N.J., Sept. 19, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced, non- [...]
Veterans Affairs Northeast Ohio Healthcare System Receives Spinal Cord Rehabilitation Exoskeleton from SoldierStrong
19/09/2019
CLEVELAND, Sept. 19, 2019 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit organization dedicated to providing revolutionary medical technologies to help injured veterans lead full lives, donated an Indego [...]
BriaCell Announces Public Disclosure: Remarkable Responder in Combination Study of Lead Candidate with KEYTRUDA®
19/09/2019
Material information is being presented concurrent with this press release at 9:35am Eastern Time at the Next Gen Immuno-Oncology Congress. Publicly-traded securities of BriaCell Therapeutics Corp. (TSX-V:BCT) (OTCQB: [...]
MannKind Presents Positive Afrezza® Clinical Data from Type 1 Diabetes Study at 55th Annual Meeting of the EASD
19/09/2019
WESTLAKE VILLAGE, Calif., Sept. 19, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) announced that data from a one-year study of Afrezza® (insulin human) Inhalation Powder was presented at the 55 th Annual [...]

Pages